MedPharm has announced internal investment of nearly $1 million on cutting edge instrumentation for its U.S. facilities based in Durham, NC.
The investment covers the latest Hamilton Vantage robot for sample handling, an ultra-performance liquid chromatography tandem mass spectrometry instrument (UPLC-MS/MS) and a UHPLC with both UV-VIS and fluorescence detectors. In addition the US site has also expanded its workforce to over 20 scientists and support staff.
The new Hamilton Vantage robot is the first of its type to be installed in the Southeast U.S. and will reduce testing variation as well as increase throughput. The UPLC-triple quadrupole mass spectrometer system from Waters is the third LC-MS/MS to be installed in the MedPharm US. This new system allows very high sensitivity analyses and enables MedPharm’s customers to achieve low picogram per milliliter detection limits in pharmacokinetic and performance testing studies.
“This significant investment in both equipment and staff highlights MedPharm’s determination to expand our capabilities to meet growing customer demand for our services and also to stay at the forefront of the technology beneficial to the sectors in which we operate,” said Jon Lenn, MedPharm’s senior vice president of U.S. Operations. “As regulatory demands increase, this new equipment allows us to maintain our leading edge in the pharmaceutical formulation development and testing sectors for topical and transdermal products”.